Secant embraces your mission to revolutionize medicine by evolving our biomaterials to meet the challenge. By developing textiles, polymers, and hybrids at scale.

Secant offers many opportunities to develop and expand your career while making a difference. Our team works in a high-energy, collaborative environment to develop high-performance, custom …

Experts from Solesis, parent company of Secant Group, discuss how polymer science enables the development of biomaterials such as implantable textiles and single-use solutions for medical device …

Aug 26, 2022 · Secant Group designs and develops custom-engineered, next-generation textiles and biomaterials solutions that enable repair, recovery, and regeneration of the human body.

Leveraging fiber and polymer expertise, Secant Group custom designs critical medical device components based on performance and biocompatibility requirements.

Secant Group can manufacture medical device components from any fiber or yarn from start to finish. We are an ISO 13485:2016-certified manufacturing facility.

Secant has developed Hydralese-based microspheres for controlled drug delivery. Microspheres or microparticles are a multi-particulate drug delivery system that can be administered parenterally or …

Aug 1, 2023 · From prototyping to commercialization, Secant Group is the collaborative, integrated partner of choice in the cardiovascular, neurovascular, orthopedic, surgical, and pharmaceutical …

Whether you’re creating a new device or enhancing a predicate device, manufacturers can count on Secant Group’s broad portfolio of advanced textile solutions and services to deliver high quality and …

Secant Group’s Hydralese® polymer platform can be leveraged to enable innovative custom-developed solutions for complex long-acting drug delivery challenges.